Revista chilena de radiología
versión On-line ISSN 0717-9308
UCHIDA S, Marcela et al. Is breast MRI concordant with pathologic tumor size in breast cancer patients treated with neoadjuvant chemotherapy?. Rev. chil. radiol. [online]. 2012, vol.18, n.2, pp. 74-78. ISSN 0717-9308. http://dx.doi.org/10.4067/S0717-93082012000200007.
Neoadjuvant chemotherapy (NACT) is a treatment used in those breast cancers initially inoperable due to their size, and also in operable breast cancers where NACT could increase the rate of conservative breast surgery. To assess tumor response to treatment, clinical examination, mammography, ultrasound, and breast MRI are used, the latter being the modality that yields the best correlation with histologic tumor volume. We evaluated the correlation of tumor sizes as measured by MRI versus surgical pathological specimen in breast cancers treated with NACT. Eighteen patients underwent MRI to monitor NACT; in 15 (83%) of them the final biopsy was obtained. In this group a very good correlation was observed, with a mean difference between MRI and histology of 4 mm regarding tumor volumen, which has allowed an adequate management of patients in our daily practice.
Palabras llave : Breast MRI; Conservative breast surgery; Neoadjuvant chemotherapy.